FDA Inspection 991276 — BioMarin Pharmaceutical, Inc.
The FDA completed an inspection of BioMarin Pharmaceutical, Inc. on November 4, 2016 in Novato, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 4, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Novato, CA (United States)
Additional Details
Sponsor, Contract Research Organization